EMD Serono facility expansion in Massachusetts set to advance immuno-oncology research
German pharmaceutical giant Merck KGaA has announced a significant investment of $70 million to expand its EMD Serono research and development (R&D) facility located in Billerica, Massachusetts. This expansion, which includes the construction of a new building, is set to drive innovations in critical areas like oncology, immuno-oncology, and immunology, helping the company advance its […]
